Erratum: Phosphorylated ribosomal protein S6 is required for Akt-driven hyperplasia and malignant transformation, but not for hypertrophy, aneuploidy and hyperfunction of pancreatic β-cells (PLoS ONE (2016) 11:2 (e0149995) DOI: 10.1371/journal.pone.0149995)

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

The first author’s name appears incorrectly in the article citation. The correct citation is: Wittenberg Dreazen A, Azar S, Klochendler A, Stolovich-Rain M, Avraham S, Birnbaum L, et al. (2016) Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells. PLoS ONE 11(2): e0149995. doi:10.1371/journal.pone.0149995. Table 1 appears incorrectly in the published article. The last six rows are duplicates of the six above them. Please see the correct Table 1 and its caption below. The publisher apologizes for the error. (Table Presented).

Cite

CITATION STYLE

APA

Erratum: Phosphorylated ribosomal protein S6 is required for Akt-driven hyperplasia and malignant transformation, but not for hypertrophy, aneuploidy and hyperfunction of pancreatic β-cells (PLoS ONE (2016) 11:2 (e0149995) DOI: 10.1371/journal.pone.0149995). (2016, May 1). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0155281

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free